Pappas N J
Clin Chim Acta. 1986 Feb 15;154(3):181-9. doi: 10.1016/0009-8981(86)90029-x.
Repeated doses of the protein synthesis inhibitor cycloheximide prevented the increases in rat liver mitochondrial and cytosolic aspartate aminotransferase, in alanine aminotransferase and in protein content observed 24 h after a single carbon tetrachloride injection. Serum aminotransferase activity increases induced by carbon tetrachloride were also decreased as much as 75.7% with cycloheximide. Increased synthesis is, therefore, suggested as an important and sometimes major source of increased serum aminotransferases in hepatocellular injury. This effect of cycloheximide lends support to the hypothesis that the liver enzyme increases after CCl4 are probably due to increased synthesis, in addition to the classically held mechanisms of leakage from necrotic or damaged hepatocytes. This explanation of the mechanisms of release of aminotransferases in rat liver injury would clarify many clinical observations if the same phenomenon were to occur in humans in response to hepatic injury. These data suggest that increased serum aminotransferase activities represent a healing, in addition to a degenerative, process.
重复给予蛋白质合成抑制剂环己酰亚胺可阻止在单次注射四氯化碳24小时后观察到的大鼠肝脏线粒体和胞质中天冬氨酸转氨酶、丙氨酸转氨酶以及蛋白质含量的增加。环己酰亚胺还可使四氯化碳诱导的血清转氨酶活性增加降低多达75.7%。因此,合成增加被认为是肝细胞损伤时血清转氨酶升高的一个重要且有时是主要的来源。环己酰亚胺的这种作用支持了以下假说:除了传统认为的坏死或受损肝细胞渗漏机制外,四氯化碳处理后肝脏酶的增加可能是由于合成增加所致。如果人类肝脏损伤时也出现相同现象,那么这种对大鼠肝脏损伤中转氨酶释放机制的解释将阐明许多临床观察结果。这些数据表明,血清转氨酶活性增加不仅代表一个退化过程,还代表一个修复过程。